Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kylie J Mansfield. (2010) Role of fesoterodine in the treatment of overactive bladder. Open Access Journal of Urology 2, pages 1-9.
Read now
Read now
Scott R. Serels, Marc R. Toglia, Sergio Forero-Schwanhaeuser & Weizhong He. (2010) Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms. Current Medical Research and Opinion 26:10, pages 2277-2285.
Read now
Read now
Dudley Robinson & Linda Cardozo. (2009) Solifenacin: pharmacology and clinical efficacy. Expert Review of Clinical Pharmacology 2:3, pages 239-253.
Read now
Read now
Articles from other publishers (24)
Akvile Stoniute, Priya Madhuvrata, Madeleine Still, Evelyn Barron-Millar, Ghulam Nabi & Muhammad Imran Omar. (2023) Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Crossref
Byungkook Oh, Young-Soo Lim, Kun Woo Ko, Hyeonyeob Seo, Dong Jun Kim, Dukyoo Kong, Jae Min You, Hansoul Kim, Taek-Soo Kim, Seongjun Park, Dong-Soo Kwon, Joon Chae Na, Woong Kyu Han, Sung-Min Park & Steve Park. (2023) Ultra-soft and highly stretchable tissue-adhesive hydrogel based multifunctional implantable sensor for monitoring of overactive bladder. Biosensors and Bioelectronics 225, pages 115060.
Crossref
Crossref
Ji Sung Shim, Sung Gu Kang, Jae Young Park, Jae Hyun Bae, Seok Ho Kang, Hong Seok Park, Du Geon Moon, Jun Cheon, Jeong Gu Lee, Je Jong Kim & Mi Mi Oh. (2016) Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder. Urology 94, pages 64-69.
Crossref
Crossref
Satoru TAKAHASHI, Mineo TAKEI, Osamu NISHIZAWA, Osamu YAMAGUCHI, Kumiko KATO, Momokazu GOTOH, Yasukuni YOSHIMURA, Masami TAKEYAMA, Hideo OZAWA, Makoto SHIMADA, Tomonori YAMANISHI, Masaki YOSHIDA, Hikaru TOMOE, Osamu YOKOYAMA & Masayasu KOYAMA. (2016) Clinical Guideline for Female Lower Urinary Tract Symptoms. LUTS: Lower Urinary Tract Symptoms 8:1, pages 5-29.
Crossref
Crossref
Johan Vande Walle & Søren Rittig. 2016. Pediatric Kidney Disease. Pediatric Kidney Disease
1193
1220
.
Jae Hoon Chung, Joo Yong Lee, Dong Hyuk Kang, U‐Syn Ha, Seung Hwan Lee, Won Sik Ham, Kang Su Cho, June Hyun Han, Jinsung Park, Tag Keun Yoo & Seung Wook Lee. (2012) Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open‐label, multicenter, prospective study. Neurourology and Urodynamics 31:7, pages 1175-1180.
Crossref
Crossref
Salvador Arlandis-Guzman, Carlos Errando-Smet, Jeffrey Trocio, Daniel Arumi & Javier Rejas. (2011) Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model. BMC Urology 11:1.
Crossref
Crossref
Dudley Robinson & Linda Cardozo. (2011) Solifenacin for the treatment of overactive bladder. Therapy 8:6, pages 691-701.
Crossref
Crossref
Michael G. Oefelein. (2011) Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder. Drug Safety 34:9, pages 733-754.
Crossref
Crossref
C. C. Sexton, S. M. Notte, C. Maroulis, R. R. Dmochowski, L. Cardozo, D. Subramanian & K. S. Coyne. (2011) Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. International Journal of Clinical Practice 65:5, pages 567-585.
Crossref
Crossref
Vincent Lucente, Donald R. Ostergard, G. Willy Davila, Weizhong He, Gregory P. Gilmet & Sergio Forero-Schwanhaeuser. (2010) Efficacy of Solifenacin on Symptom Bother and Health-Related Quality of Life in Patients With Acute, Early Chronic, and Late Chronic Overactive Bladder. Female Pelvic Medicine & Reconstructive Surgery 16:6, pages 320-326.
Crossref
Crossref
D. R. Staskin & L. Cardozo. (2009) Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release. International Journal of Clinical Practice 63:6, pages 973-976.
Crossref
Crossref
Oxana Doroshyenko & Uwe Fuhr. (2009) Clinical Pharmacokinetics and Pharmacodynamics of Solifenacin. Clinical Pharmacokinetics 48:5, pages 281-302.
Crossref
Crossref
Kylie J. Mansfield, Jonathan J. Chandran, Kenneth J. Vaux, Richard J. Millard, Arthur Christopoulos, Frederick J. Mitchelson & Elizabeth Burcher. (2009) Comparison of Receptor Binding Characteristics of Commonly Used Muscarinic Antagonists in Human Bladder Detrusor and Mucosa. Journal of Pharmacology and Experimental Therapeutics 328:3, pages 893-899.
Crossref
Crossref
Osamu Yamaguchi, Osamu Nishizawa, Masayuki Takeda, Osamu Yokoyama, Yukio Homma, Hidehiro Kakizaki, Kenji Obara, Momokazu Gotoh, Yasuhiko Igawa, Naarihito Seki & Masaki Yoshida. (2009) Clinical guidelines for overactive bladder. International Journal of Urology 16:2, pages 126-142.
Crossref
Crossref
Roger Dmochowski, Andrea Larson-Peters, William Aronstein & Yodit Seifu. (2009) Efficacy of Darifenacin in Patients with Varying Baseline Symptom Severity. UroToday International Journal 02:03.
Crossref
Crossref
Steven E. Swift, Paul Siami & Sergio Forero-Schwanhaeuser. (2009) Diary and Patient-Reported Outcomes in Patients with Severe Overactive Bladder Switching from Tolterodine Extended Release 4 mg/day to Solifenacin Treatment. Clinical Drug Investigation 29:5, pages 305-316.
Crossref
Crossref
J.K. Aronson. 2009.
259
285
.
a. e. bharucha, b. seide, z. guan, c. n. andrews & a. r. zinsmeister. (2008) Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects. Neurogastroenterology & Motility 20:6, pages 643-648.
Crossref
Crossref
. (2007) Current World Literature. Current Opinion in Urology 17:4, pages 287-292.
Crossref
Crossref
Donna J Sellers & Neil McKay. (2007) Developments in the pharmacotherapy of the overactive bladder. Current Opinion in Urology 17:4, pages 223-230.
Crossref
Crossref
Maria Maniscalco, Devada Singh-Franco, William R. Wolowich & Rolando Torres-Colón. (2006) Solifenacin succinate for the treatment of symptoms of overactive bladder. Clinical Therapeutics 28:9, pages 1247-1272.
Crossref
Crossref
Jean-Jacques Wyndaele. (2006) Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity. Therapy 3:4, pages 485-494.
Crossref
Crossref
Stefano Salvatore, Maurizio Serati, Matteo Zanfrà, Evelina Bertelli & Pierfrancesco Bolis. (2006) Overactive Bladder Syndrome: Considerations in Pharmacotherapy and New Perspectives. Gynäkologisch-geburtshilfliche Rundschau 46:3, pages 83-87.
Crossref
Crossref